Awards

The EHA Board selects a winner every year and the presentation of this award is made in the Welcome Ceremony of the Annual Congress in which the winner is invited to give a lecture of 30 minutes. Candidates for this award are basic scientist and clinicians in alternating years and selection of the winner is based on a number of criteria like support to European Hematology, area of expertise, eligibility, other awards, gender and country of origin. The selection committee for this award consists of the EHA President, Chair Scientific Program Committee and Congress President.

Winner 2008: Prof John Goldman

We are pleased to announce that the winner of the José Carreras - EHA Award of 2008 is Prof. John Goldman, United Kingdom.

The title of his lecture, delivered at the 13th EHA Congress, is: "Achievements for the treatment of chronic myeloid leukemia patients and European hematology in general."

The previous winners of the José Carreras - EHA Award

The first EHA Jean Bernard Lifetime Achievement Award will be presented to Prof Dr Dieter Hoelzer during the 13th Congress of the EHA in Copenhagen (June 12 -15, 2008).

Jean A Bernard (May 26, 1907 - April 17, 2006, ) was a French physician and hematologist. He was professor of hematology and director of the Institute for Leukemia at the University of Paris. After graduating in medicine in Paris in 1926 Bernard commenced his laboratory training with the bacteriologist Gaston Ramon at the Pasteur Institute in 1929.

In 1932 Bernard gave the first description of the use of high dosage radiotherapy in the treatment of Hodgkin's disease. Bernard's research has ranged from the demonstration of neoplastic nature of leukemia (1933-1937) to the formulation of methods of treatment. Bernard gave his name to Bernard's syndrome and Bernard-Soulier syndrome. In all, Bernard published 14 textbooks and monographs on hematology. He was elected at the Académie Française on March 18, 1976.
In 1981 he was elected as a member of SerbianAcademy of Sciences and Arts in the Department of Medical Sciences. In 1983, he was awarded the Artois-Baillet Latour Health Prize.

In 1947, he and Dr Marcel Bessis developed exchange blood transfusion as a therapy for childhood leukemia. The transfusions induced what is believed to have been the first temporary remission of acute lymphoblastic leukemia in children

In 1948, Dr Bernard and Dr Jean-Pierre Soulier described a hereditary syndrome that did not allow platelets to stick to blood vessels and form clots. It leads to bleeding in children and is now known as the Bernard-Soulier syndrome.